8月7日，昭衍新药（06127.HK）盘中上涨5.63%，报25.9港元，成交额1.08亿港元。
消息面上，生命科学工具和服务板块延续强势，康龙化成涨9.46%、药明合联涨7.94%、药明生物涨6.14%、药明康德涨5.84%，板块全线走强。此前药明康德披露半年报，上半年营收288.97亿元同比增长38.93%，扣非净利润同比增长89.39%，并全面上调全年业绩指引，持续提振CXO板块情绪。叠加行业多家头部企业一季度新签订单大幅增长，CRO/CDMO行业订单回暖趋势延续，带动板块联动上行。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.